Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Viburnum opulus*, commonly known as cramp bark, guelder rose, or gilaburu, is a deciduous shrub whose fruits, bark, and seeds are utilized in traditional medicine, homeopathy, and functional foods. It is notably investigated for the treatment of primary dysmenorrhea, where it is used as a homeopathic preparation (e.g., Viburnum opulus 3X) to alleviate uterine cramping and pain through its antispasmodic properties. The plant's therapeutic profile is largely attributed to its high concentration of bioactive phenolic compounds, including chlorogenic acid, anthocyanins, and flavonoids, which exert significant antioxidant, anti-inflammatory, and antidiabetic effects. Its pharmacological mechanisms include the inhibition of carbohydrate-digesting enzymes such as alpha-glucosidase and alpha-amylase, as well as the suppression of pro-inflammatory enzymes like lipoxygenase (LOX) and xanthine oxidase (XO). Recent biotechnology research has also explored the isolation of *Viburnum opulus*-derived nanovesicles, which exhibit selective cytotoxic and anti-migratory properties against glioblastoma cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on viburnum opulus.